11.5.6. Policy
tools
European Commission
Since 1999, the
EU has had the mandate, under Article 152 of the Treaty, to legislate on
quality and safety standards for human tissues and cells, human organs and
blood used in medical treatment. EU Directives have been adopted on blood (
http://ec.europa.eu/health/ph_threats/human_substance/legal_blood_en.htm),
on tissues and on cells (
http://ec.europa.eu/health/ph_threats/human_substance/legal_tissues_cells_en.htm).
A similar Directive on the quality and safety of organs could be envisaged in
the future.
The European Commission has already undertaken a number of
initiatives in various policy areas.
·
The Health and Consumer
Protection Directorate General has been working on two projects to develop a
European Training Program on Organ Donation and to contribute to create a
consensus on European common standards regarding legal, ethical, protection and
registration practices in relation to organ living donors to guarantee the
health and safety of the donors.
·
The Information Society
Directorate General is supporting the creation of a European registry on
organs, cells and tissues through the EUROCET project (
https://www.eurodonor.org/eurocet/).
·
In the area of research,
a number of projects are being carried out. For example, there is a project to
develop a list of national and regional research programmes on organ
transplantation in order to maximise the research already being carried out and
avoid duplication. A separate European research project is focusing on ways to
increase the potential of organ donation, e.g. by promoting cooperation and
sharing information and best practices among certain European countries.
Another project is focused on reprogramming the immune
system to tolerate transplanted organs.
Council of Europe
In 1987, the Council of Europe set up the Select Committee
of Experts on the organisational aspects of cooperation in organ
transplantation (SP-CTO). This group prepared many recommendations for the
Committee of Ministers. The Expert Group has now changed into a Steering
Committee on Transplantation (CD-PTO) and will continue its work on ethical and
organisational aspects.
A new step was reached with the Oviedo Convention adopted
in 1997 by the Council of Europe since its influence is more significant than a
simple recommendation or resolution. The aim of the Convention is, as defined
in article 1, to protect the human being in his/her dignity and identity, and
to guarantee anybody without discrimination the respect of his/her integrity
and other fundamental rights and liberties concerning the application of
biology and medicine. This convention has an annex: Additional Protocol
relating to human organ and tissue transplantation dated January 24, 2002.
Article 21 bans any financial aspect in this domain. The Council of Europe also
set up a group of specialists on quality assurance for organs, tissues and
cells and drew up a “Guide to Safety and Quality Assurance for Organs, Tissues
and Cells” in February 2002, updated in 2006 and 2007.
Annex 11.7.1. List of recommendations and publications in the
organ transplantation field
2005
Recommendation Rec(2005)11 on the role and training of professionals responsible for organ
donation (transplant “donor co-ordinators”)
2004
Guide to safety and quality assurance for
organs, tissues and cells – 2nd Edition (2004)
2004
Transplant Newsletter – September 2004 Vol.
9 No. 1
2004
Recommendation Rec(2004)19 on criteria for the authorisation of organ transplantation
facilities
2004
Recommendation Rec (2004)8 on autologous cord blood banks and explanatory memorandum
2004
Replies to the questionnaire for member
states on organ trafficking
2004
Recommendation Rec(2004)7 on organ trafficking
2003
Recommendation Rec(2003)12 on organ donor registers
2003
Recommendation Rec(2003)10 on xenotransplantation and
explanatory memorandum
2003
Recommendation 1611 (2003) of the Parliamentary Assembly on trafficking in organs in Europe
2003
State of the art report in the field of
xenotransplantation
2001
Recommendation Rec(2001)5 on the management of organ transplant
waiting lists and waiting times
2001
Recommendation Rec(2001)4 on the prevention of the possible transmission
of variant Creutzfeldt-Jakob Disease (vCJD) by blood transfusion
1999 Meeting the organ shortage: Current status
and strategies for improvement of organ donation – a European consensus
document
1997
Recommendation No. R (97) 16 on liver transplantation from living
related donors
1997
Recommendation No. R (97) 15 on xenotransplantation
1994
Recommendation N° R (94) 1 - Human tissue banks
1994
Recommendation 1240 of the Parliamentary Assembly on the protection of material of
human origin
1994
Recommendation (94) 1 on human tissue banks
1992 List of tissue typing laboratories in the
member states of the Council of Europe
1987 3rd Conference of European
Ministers of Health (Paris, 16-17 November 1987) - Reports:
▪ Ethical and
socio-cultural problems raised by organ transplantation
▪ Organisational and educational aspects of organ
transplantation
▪ Legislative measures in relation to organ
transplantation and to European co-operation
▪ Procurement and sharing of organs for highly immunised
recipients
▪ Current legislation in Council of Europe member states
and Finland and results of European co-operation
1987 Renal transplantation: sense and sensitization by B Bradley and S Gore,
Martinus Nijhoff Publishers
1983 Essential aspects of tissue typing
1978
Resolution (78) 29 - Harmonisation of legislations of member States relating to
removal, grafting and transplantation of human substances
·
Recommendation No. R (99) 21 of the Committee of Ministers to member states on
criteria for the management of waiting lists and waiting times in health care
(adopted at the 681st meeting)
·
Convention for the Protection of Individuals
with regard to Automatic Processing of Personal Data (ETS No. 108) and to
Recommendation No. R (97) 5 on the protection of medical data
·
World Health Organisation Resolution WHA 42.5
condemning the purchase and sale of organs of human origin
Transplantation in general has higher
measurable quality indicators than other replacement therapies. Results of
organ transplantation are progressively improving over time. This improvement
is due to the progress made in surgical techniques, the availability of new and
more specific immunosuppressive drugs, and the experience acquired by the
transplant surgical and medical teams.